The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Generic Injection-Global Market Insights and Sales Trends 2025
Synopsis
Generic injections are injections that have the same active ingredients, the same dosage, the same route of administration, the same dosage form, and the same indications as the original drug.
The global Generic Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Generic Injection in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Generic Injection market. Liquid Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder for Injection segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Generic Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Generic Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Generic Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Generic Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Generic Injection covered in this report include Sanofi, Fresenius, Viatris, Pfizer, Teva Pharmaceuticals, Hikma Pharmaceuticals, Novartis, Amneal Pharmaceuticals and Gland Pharma, etc.
The global Generic Injection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Fresenius
Viatris
Pfizer
Teva Pharmaceuticals
Hikma Pharmaceuticals
Novartis
Amneal Pharmaceuticals
Gland Pharma
Allergan
Kelun Pharmaceutical
Jiangsu HRS
Qilu Pharmaceutical
Chiatai Tianqing
Hainan Poly Pharm
Yangzijiang Pharmaceutical Industry
Shijiazhuang Pharma Group
Global Generic Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Generic Injection market, Segment by Type:
Liquid Injection
Powder for Injection
Global Generic Injection market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Generic Injection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Generic injections are injections that have the same active ingredients, the same dosage, the same route of administration, the same dosage form, and the same indications as the original drug.
The global Generic Injection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Generic Injection in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Generic Injection market. Liquid Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder for Injection segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Generic Injection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Generic Injection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Generic Injection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Generic Injection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Generic Injection covered in this report include Sanofi, Fresenius, Viatris, Pfizer, Teva Pharmaceuticals, Hikma Pharmaceuticals, Novartis, Amneal Pharmaceuticals and Gland Pharma, etc.
The global Generic Injection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Fresenius
Viatris
Pfizer
Teva Pharmaceuticals
Hikma Pharmaceuticals
Novartis
Amneal Pharmaceuticals
Gland Pharma
Allergan
Kelun Pharmaceutical
Jiangsu HRS
Qilu Pharmaceutical
Chiatai Tianqing
Hainan Poly Pharm
Yangzijiang Pharmaceutical Industry
Shijiazhuang Pharma Group
Global Generic Injection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Generic Injection market, Segment by Type:
Liquid Injection
Powder for Injection
Global Generic Injection market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Generic Injection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Generic Injection
1.1 Generic Injection Market Overview
1.1.1 Generic Injection Product Scope
1.1.2 Generic Injection Market Status and Outlook
1.2 Global Generic Injection Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Generic Injection Market Size by Region (2018-2029)
1.4 Global Generic Injection Historic Market Size by Region (2018-2023)
1.5 Global Generic Injection Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Generic Injection Market Size (2018-2029)
1.6.1 North America Generic Injection Market Size (2018-2029)
1.6.2 Europe Generic Injection Market Size (2018-2029)
1.6.3 Asia-Pacific Generic Injection Market Size (2018-2029)
1.6.4 Latin America Generic Injection Market Size (2018-2029)
1.6.5 Middle East & Africa Generic Injection Market Size (2018-2029)
2 Generic Injection Market by Type
2.1 Introduction
2.1.1 Liquid Injection
2.1.2 Powder for Injection
2.2 Global Generic Injection Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Generic Injection Historic Market Size by Type (2018-2023)
2.2.2 Global Generic Injection Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Generic Injection Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Generic Injection Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Generic Injection Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Generic Injection Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Generic Injection Revenue Breakdown by Type (2018-2029)
3 Generic Injection Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Generic Injection Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Generic Injection Historic Market Size by Application (2018-2023)
3.2.2 Global Generic Injection Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Generic Injection Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Generic Injection Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Generic Injection Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Generic Injection Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Generic Injection Revenue Breakdown by Application (2018-2029)
4 Generic Injection Competition Analysis by Players
4.1 Global Generic Injection Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Generic Injection as of 2022)
4.3 Date of Key Players Enter into Generic Injection Market
4.4 Global Top Players Generic Injection Headquarters and Area Served
4.5 Key Players Generic Injection Product Solution and Service
4.6 Competitive Status
4.6.1 Generic Injection Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Generic Injection Products, Services and Solutions
5.1.4 Sanofi Generic Injection Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Fresenius
5.2.1 Fresenius Profile
5.2.2 Fresenius Main Business
5.2.3 Fresenius Generic Injection Products, Services and Solutions
5.2.4 Fresenius Generic Injection Revenue (US$ Million) & (2018-2023)
5.2.5 Fresenius Recent Developments
5.3 Viatris
5.3.1 Viatris Profile
5.3.2 Viatris Main Business
5.3.3 Viatris Generic Injection Products, Services and Solutions
5.3.4 Viatris Generic Injection Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Generic Injection Products, Services and Solutions
5.4.4 Pfizer Generic Injection Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Teva Pharmaceuticals
5.5.1 Teva Pharmaceuticals Profile
5.5.2 Teva Pharmaceuticals Main Business
5.5.3 Teva Pharmaceuticals Generic Injection Products, Services and Solutions
5.5.4 Teva Pharmaceuticals Generic Injection Revenue (US$ Million) & (2018-2023)
5.5.5 Teva Pharmaceuticals Recent Developments
5.6 Hikma Pharmaceuticals
5.6.1 Hikma Pharmaceuticals Profile
5.6.2 Hikma Pharmaceuticals Main Business
5.6.3 Hikma Pharmaceuticals Generic Injection Products, Services and Solutions
5.6.4 Hikma Pharmaceuticals Generic Injection Revenue (US$ Million) & (2018-2023)
5.6.5 Hikma Pharmaceuticals Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Generic Injection Products, Services and Solutions
5.7.4 Novartis Generic Injection Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 Amneal Pharmaceuticals
5.8.1 Amneal Pharmaceuticals Profile
5.8.2 Amneal Pharmaceuticals Main Business
5.8.3 Amneal Pharmaceuticals Generic Injection Products, Services and Solutions
5.8.4 Amneal Pharmaceuticals Generic Injection Revenue (US$ Million) & (2018-2023)
5.8.5 Amneal Pharmaceuticals Recent Developments
5.9 Gland Pharma
5.9.1 Gland Pharma Profile
5.9.2 Gland Pharma Main Business
5.9.3 Gland Pharma Generic Injection Products, Services and Solutions
5.9.4 Gland Pharma Generic Injection Revenue (US$ Million) & (2018-2023)
5.9.5 Gland Pharma Recent Developments
5.10 Allergan
5.10.1 Allergan Profile
5.10.2 Allergan Main Business
5.10.3 Allergan Generic Injection Products, Services and Solutions
5.10.4 Allergan Generic Injection Revenue (US$ Million) & (2018-2023)
5.10.5 Allergan Recent Developments
5.11 Kelun Pharmaceutical
5.11.1 Kelun Pharmaceutical Profile
5.11.2 Kelun Pharmaceutical Main Business
5.11.3 Kelun Pharmaceutical Generic Injection Products, Services and Solutions
5.11.4 Kelun Pharmaceutical Generic Injection Revenue (US$ Million) & (2018-2023)
5.11.5 Kelun Pharmaceutical Recent Developments
5.12 Jiangsu HRS
5.12.1 Jiangsu HRS Profile
5.12.2 Jiangsu HRS Main Business
5.12.3 Jiangsu HRS Generic Injection Products, Services and Solutions
5.12.4 Jiangsu HRS Generic Injection Revenue (US$ Million) & (2018-2023)
5.12.5 Jiangsu HRS Recent Developments
5.13 Qilu Pharmaceutical
5.13.1 Qilu Pharmaceutical Profile
5.13.2 Qilu Pharmaceutical Main Business
5.13.3 Qilu Pharmaceutical Generic Injection Products, Services and Solutions
5.13.4 Qilu Pharmaceutical Generic Injection Revenue (US$ Million) & (2018-2023)
5.13.5 Qilu Pharmaceutical Recent Developments
5.14 Chiatai Tianqing
5.14.1 Chiatai Tianqing Profile
5.14.2 Chiatai Tianqing Main Business
5.14.3 Chiatai Tianqing Generic Injection Products, Services and Solutions
5.14.4 Chiatai Tianqing Generic Injection Revenue (US$ Million) & (2018-2023)
5.14.5 Chiatai Tianqing Recent Developments
5.15 Hainan Poly Pharm
5.15.1 Hainan Poly Pharm Profile
5.15.2 Hainan Poly Pharm Main Business
5.15.3 Hainan Poly Pharm Generic Injection Products, Services and Solutions
5.15.4 Hainan Poly Pharm Generic Injection Revenue (US$ Million) & (2018-2023)
5.15.5 Hainan Poly Pharm Recent Developments
5.16 Yangzijiang Pharmaceutical Industry
5.16.1 Yangzijiang Pharmaceutical Industry Profile
5.16.2 Yangzijiang Pharmaceutical Industry Main Business
5.16.3 Yangzijiang Pharmaceutical Industry Generic Injection Products, Services and Solutions
5.16.4 Yangzijiang Pharmaceutical Industry Generic Injection Revenue (US$ Million) & (2018-2023)
5.16.5 Yangzijiang Pharmaceutical Industry Recent Developments
5.17 Shijiazhuang Pharma Group
5.17.1 Shijiazhuang Pharma Group Profile
5.17.2 Shijiazhuang Pharma Group Main Business
5.17.3 Shijiazhuang Pharma Group Generic Injection Products, Services and Solutions
5.17.4 Shijiazhuang Pharma Group Generic Injection Revenue (US$ Million) & (2018-2023)
5.17.5 Shijiazhuang Pharma Group Recent Developments
6 North America
6.1 North America Generic Injection Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Generic Injection Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Generic Injection Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Generic Injection Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Generic Injection Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Generic Injection Market Dynamics
11.1 Generic Injection Industry Trends
11.2 Generic Injection Market Drivers
11.3 Generic Injection Market Challenges
11.4 Generic Injection Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
